drugset / Trial / NCT00418756
Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will evaluate the effect of 600 mg daily oral dose of rifampin (CYP3A4 inducer) on the pharmacokinetics of a single 400 mg oral dose of nilotinib in healthy subjects
Timeline
- Start
- 2006-10
- Primary completion
- 2006-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nilotinib | Small molecule | 400 mg | Oral |
Indications
No indication recorded.